APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Alpha Synuclein

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Alpha Synuclein Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173962340319 December 2025197 pages

Choose your research edition.

Industry ResearchAlpha Synuclein Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Alpha Synuclein Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Alpha Synuclein Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Alpha Synuclein Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Alpha Synuclein Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Alpha Synuclein market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Alpha Synuclein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Alpha Synuclein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Alpha Synuclein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Alpha Synuclein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Alpha Synuclein include Biogen Inc, reMYND NV, QR Pharma Inc, Prothena Corp Plc, nLife Therapeutics SL, Neuropore Therapies Inc, MedImmune LLC, ICB International Inc and H. Lundbeck A/S, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Alpha Synuclein market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Alpha Synuclein and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Alpha Synuclein sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Alpha Synuclein market size, projected growth trends, production technologies, key applications, and end-use industries.

Alpha Synuclein Segment by Company

Biogen Inc

reMYND NV

QR Pharma Inc

Prothena Corp Plc

nLife Therapeutics SL

Neuropore Therapies Inc

MedImmune LLC

ICB International Inc

H. Lundbeck A/S

Genmab A/S

Evotec AG

BioArctic AB

AFFiRiS AG

AC Immune SA

Alpha Synuclein Segment by Type

DPC-003

BIIB-054

BAN-0805

AV-1950R

AV-1947D

Others

Alpha Synuclein Segment by Application

Multiple System Atrophy

Lewy Body Dementia

Neurodegenerateive Disease

Others

Alpha Synuclein Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alpha Synuclein market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Alpha Synuclein and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alpha Synuclein.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Alpha Synuclein market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Alpha Synuclein manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Alpha Synuclein in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Alpha Synuclein in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Alpha Synuclein Industry Trends Table 2. Alpha Synuclein Industry Drivers Table 3. Alpha Synuclein Industry Opportunities and Challenges Table 4. Alpha Synuclein Industry Restraints Table 5. Global Alpha Synuclein Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Alpha Synuclein Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Alpha Synuclein Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Alpha Synuclein Sales Market Share by Manufacturers Table 9. Global Alpha Synuclein Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Alpha Synuclein Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Alpha Synuclein Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Alpha Synuclein Manufacturers, Product Type & Application Table 13. Global Alpha Synuclein Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Alpha Synuclein by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of DPC-003 Table 17. Major Manufacturers of BIIB-054 Table 18. Major Manufacturers of BAN-0805 Table 19. Major Manufacturers of AV-1950R Table 20. Major Manufacturers of AV-1947D Table 21. Major Manufacturers of Others Table 22. Global Alpha Synuclein Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Alpha Synuclein Sales by Type (2021-2026) & (K Units) Table 24. Global Alpha Synuclein Sales by Type (2027-2032) & (K Units) Table 25. Global Alpha Synuclein Sales Market Share by Type (2021-2026) Table 26. Global Alpha Synuclein Sales Market Share by Type (2027-2032) Table 27. Global Alpha Synuclein Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 28. Global Alpha Synuclein Revenue by Type (2021-2026) & (K Units) Table 29. Global Alpha Synuclein Revenue by Type (2027-2032) & (K Units) Table 30. Global Alpha Synuclein Revenue Market Share by Type (2021-2026) Table 31. Global Alpha Synuclein Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Multiple System Atrophy Table 33. Major Manufacturers of Lewy Body Dementia Table 34. Major Manufacturers of Neurodegenerateive Disease Table 35. Major Manufacturers of Others Table 36. Global Alpha Synuclein Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Alpha Synuclein Sales by Application (2021-2026) & (K Units) Table 38. Global Alpha Synuclein Sales by Application (2027-2032) & (K Units) Table 39. Global Alpha Synuclein Sales Market Share by Application (2021-2026) Table 40. Global Alpha Synuclein Sales Market Share by Application (2027-2032) Table 41. Global Alpha Synuclein Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 42. Global Alpha Synuclein Revenue by Application (2021-2026) & (K Units) Table 43. Global Alpha Synuclein Revenue by Application (2027-2032) & (K Units) Table 44. Global Alpha Synuclein Revenue Market Share by Application (2021-2026) Table 45. Global Alpha Synuclein Revenue Market Share by Application (2027-2032) Table 46. Global Alpha Synuclein Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 47. Global Alpha Synuclein Sales by Region (2021-2026) & (K Units) Table 48. Global Alpha Synuclein Sales Market Share by Region (2021-2026) Table 49. Global Alpha Synuclein Sales Forecasted by Region (2027-2032) & (K Units) Table 50. Global Alpha Synuclein Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Alpha Synuclein Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. North America Alpha Synuclein Sales by Country (2021-2026) & (K Units) Table 53. North America Alpha Synuclein Sales by Country (2027-2032) & (K Units) Table 54. Europe Alpha Synuclein Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Europe Alpha Synuclein Sales by Country (2021-2026) & (K Units) Table 56. Europe Alpha Synuclein Sales by Country (2027-2032) & (K Units) Table 57. Asia Pacific Alpha Synuclein Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Asia Pacific Alpha Synuclein Sales by Country (2021-2026) & (K Units) Table 59. Asia Pacific Alpha Synuclein Sales by Country (2027-2032) & (K Units) Table 60. South America, Middle East and Africa Alpha Synuclein Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 61. South America, Middle East and Africa Alpha Synuclein Sales by Country (2021-2026) & (K Units) Table 62. South America, Middle East and Africa Alpha Synuclein Sales by Country (2027-2032) & (K Units) Table 63. Global Alpha Synuclein Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Alpha Synuclein Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Alpha Synuclein Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Alpha Synuclein Revenue Market Share by Region (2021-2026) Table 67. Global Alpha Synuclein Revenue Market Share by Region (2027-2032) Table 68. Biogen Inc Company Information Table 69. Biogen Inc Business Overview Table 70. Biogen Inc Alpha Synuclein Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Biogen Inc Alpha Synuclein Product Portfolio Table 72. Biogen Inc Recent Development Table 73. reMYND NV Company Information Table 74. reMYND NV Business Overview Table 75. reMYND NV Alpha Synuclein Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. reMYND NV Alpha Synuclein Product Portfolio Table 77. reMYND NV Recent Development Table 78. QR Pharma Inc Company Information Table 79. QR Pharma Inc Business Overview Table 80. QR Pharma Inc Alpha Synuclein Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. QR Pharma Inc Alpha Synuclein Product Portfolio Table 82. QR Pharma Inc Recent Development Table 83. Prothena Corp Plc Company Information Table 84. Prothena Corp Plc Business Overview Table 85. Prothena Corp Plc Alpha Synuclein Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Prothena Corp Plc Alpha Synuclein Product Portfolio Table 87. Prothena Corp Plc Recent Development Table 88. nLife Therapeutics SL Company Information Table 89. nLife Therapeutics SL Business Overview Table 90. nLife Therapeutics SL Alpha Synuclein Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. nLife Therapeutics SL Alpha Synuclein Product Portfolio Table 92. nLife Therapeutics SL Recent Development Table 93. Neuropore Therapies Inc Company Information Table 94. Neuropore Therapies Inc Business Overview Table 95. Neuropore Therapies Inc Alpha Synuclein Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Neuropore Therapies Inc Alpha Synuclein Product Portfolio Table 97. Neuropore Therapies Inc Recent Development Table 98. MedImmune LLC Company Information Table 99. MedImmune LLC Business Overview Table 100. MedImmune LLC Alpha Synuclein Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. MedImmune LLC Alpha Synuclein Product Portfolio Table 102. MedImmune LLC Recent Development Table 103. ICB International Inc Company Information Table 104. ICB International Inc Business Overview Table 105. ICB International Inc Alpha Synuclein Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. ICB International Inc Alpha Synuclein Product Portfolio Table 107. ICB International Inc Recent Development Table 108. H. Lundbeck A/S Company Information Table 109. H. Lundbeck A/S Business Overview Table 110. H. Lundbeck A/S Alpha Synuclein Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. H. Lundbeck A/S Alpha Synuclein Product Portfolio Table 112. H. Lundbeck A/S Recent Development Table 113. Genmab A/S Company Information Table 114. Genmab A/S Business Overview Table 115. Genmab A/S Alpha Synuclein Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Genmab A/S Alpha Synuclein Product Portfolio Table 117. Genmab A/S Recent Development Table 118. Evotec AG Company Information Table 119. Evotec AG Business Overview Table 120. Evotec AG Alpha Synuclein Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Evotec AG Alpha Synuclein Product Portfolio Table 122. Evotec AG Recent Development Table 123. BioArctic AB Company Information Table 124. BioArctic AB Business Overview Table 125. BioArctic AB Alpha Synuclein Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. BioArctic AB Alpha Synuclein Product Portfolio Table 127. BioArctic AB Recent Development Table 128. AFFiRiS AG Company Information Table 129. AFFiRiS AG Business Overview Table 130. AFFiRiS AG Alpha Synuclein Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. AFFiRiS AG Alpha Synuclein Product Portfolio Table 132. AFFiRiS AG Recent Development Table 133. AC Immune SA Company Information Table 134. AC Immune SA Business Overview Table 135. AC Immune SA Alpha Synuclein Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. AC Immune SA Alpha Synuclein Product Portfolio Table 137. AC Immune SA Recent Development Table 138. Key Raw Materials Table 139. Raw Materials Key Suppliers Table 140. Alpha Synuclein Distributors List Table 141. Alpha Synuclein Customers List Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Alpha Synuclein Product Image Figure 2. Global Alpha Synuclein Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Alpha Synuclein Market Size (2021-2032) & (US$ Million) Figure 4. Global Alpha Synuclein Sales (2021-2032) & (K Units) Figure 5. Global Alpha Synuclein Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Alpha Synuclein Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. DPC-003 Image Figure 9. BIIB-054 Image Figure 10. BAN-0805 Image Figure 11. AV-1950R Image Figure 12. AV-1947D Image Figure 13. Others Image Figure 14. Global Alpha Synuclein Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Alpha Synuclein Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Alpha Synuclein Sales Market Share by Type (2021-2032) Figure 17. Global Alpha Synuclein Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 18. Global Alpha Synuclein Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Alpha Synuclein Revenue Market Share by Type (2021-2032) Figure 20. Multiple System Atrophy Image Figure 21. Lewy Body Dementia Image Figure 22. Neurodegenerateive Disease Image Figure 23. Others Image Figure 24. Global Alpha Synuclein Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Alpha Synuclein Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Alpha Synuclein Sales Market Share by Application (2021-2032) Figure 27. Global Alpha Synuclein Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 28. Global Alpha Synuclein Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Alpha Synuclein Revenue Market Share by Application (2021-2032) Figure 30. North America Alpha Synuclein Sales and Growth Rate (2021-2032) & (K Units) Figure 31. North America Alpha Synuclein Sales Market Share by Country (2021-2032) Figure 32. U.S. Alpha Synuclein Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Canada Alpha Synuclein Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Mexico Alpha Synuclein Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Europe Alpha Synuclein Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Europe Alpha Synuclein Sales Market Share by Country (2021-2032) Figure 37. Germany Alpha Synuclein Sales and Growth Rate (2021-2032) & (K Units) Figure 38. France Alpha Synuclein Sales and Growth Rate (2021-2032) & (K Units) Figure 39. U.K. Alpha Synuclein Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Italy Alpha Synuclein Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Netherlands Alpha Synuclein Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Asia Pacific Alpha Synuclein Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Asia Pacific Alpha Synuclein Sales Market Share by Country (2021-2032) Figure 44. China Alpha Synuclein Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Japan Alpha Synuclein Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South Korea Alpha Synuclein Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Southeast Asia Alpha Synuclein Sales and Growth Rate (2021-2032) & (K Units) Figure 48. India Alpha Synuclein Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Australia Alpha Synuclein Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South America, Middle East and Africa Alpha Synuclein Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South America, Middle East and Africa Alpha Synuclein Sales Market Share by Country (2021-2032) Figure 52. Brazil Alpha Synuclein Sales and Growth Rate (2021-2032) & (K Units) Figure 53. South Africa Alpha Synuclein Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Saudi Arabia Alpha Synuclein Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Turkey Alpha Synuclein Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Argentina Alpha Synuclein Sales and Growth Rate (2021-2032) & (K Units) Figure 57. UAE Alpha Synuclein Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Egypt Alpha Synuclein Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Chile Alpha Synuclein Sales and Growth Rate (2021-2032) & (K Units) Figure 60. Global Alpha Synuclein Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Alpha Synuclein Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Alpha Synuclein Revenue (2021-2032) & (US$ Million) Figure 63. North America Alpha Synuclein Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Alpha Synuclein Revenue (2021-2032) & (US$ Million) Figure 65. Europe Alpha Synuclein Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Alpha Synuclein Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Alpha Synuclein Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Alpha Synuclein Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Alpha Synuclein Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Alpha Synuclein Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Alpha Synuclein Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • DPC-003
  • BIIB-054
  • BAN-0805
  • AV-1950R
  • AV-1947D
  • Others
Applications
  • Multiple System Atrophy
  • Lewy Body Dementia
  • Neurodegenerateive Disease
  • Others
Companies covered
  • Biogen Inc
  • reMYND NV
  • QR Pharma Inc
  • Prothena Corp Plc
  • nLife Therapeutics SL
  • Neuropore Therapies Inc
  • MedImmune LLC
  • ICB International Inc
  • H. Lundbeck A/S
  • Genmab A/S
  • Evotec AG
  • BioArctic AB
  • AFFiRiS AG
  • AC Immune SA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Alpha Synuclein Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Alpha Synuclein Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Alpha Synuclein Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Alpha Synuclein Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Alpha Synuclein Market Dynamics
  1. 2.1 Alpha Synuclein Industry Trends
  2. 2.2 Alpha Synuclein Industry Drivers
  3. 2.3 Alpha Synuclein Industry Opportunities and Challenges
  4. 2.4 Alpha Synuclein Industry Restraints
3 Alpha Synuclein Market by Manufacturers
  1. 3.1 Global Alpha Synuclein Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Alpha Synuclein Sales by Manufacturers (2021-2026)
  3. 3.3 Global Alpha Synuclein Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Alpha Synuclein Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Alpha Synuclein Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Alpha Synuclein Manufacturers, Product Type & Application
  7. 3.7 Global Alpha Synuclein Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Alpha Synuclein Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Alpha Synuclein Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Alpha Synuclein Tier 1, Tier 2, and Tier 3
4 Alpha Synuclein Market by Type
  1. 4.1 Alpha Synuclein Type Introduction
  2. 4.1.1 DPC-003
  3. 4.1.2 BIIB-054
  4. 4.1.3 BAN-0805
  5. 4.1.4 AV-1950R
  6. 4.1.5 AV-1947D
  7. 4.1.6 Others
  8. 4.2 Global Alpha Synuclein Sales by Type
  9. 4.2.1 Global Alpha Synuclein Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Alpha Synuclein Sales by Type (2021-2032)
  11. 4.2.3 Global Alpha Synuclein Sales Market Share by Type (2021-2032)
  12. 4.3 Global Alpha Synuclein Revenue by Type
  13. 4.3.1 Global Alpha Synuclein Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Alpha Synuclein Revenue by Type (2021-2032)
  15. 4.3.3 Global Alpha Synuclein Revenue Market Share by Type (2021-2032)
5 Alpha Synuclein Market by Application
  1. 5.1 Alpha Synuclein Application Introduction
  2. 5.1.1 Multiple System Atrophy
  3. 5.1.2 Lewy Body Dementia
  4. 5.1.3 Neurodegenerateive Disease
  5. 5.1.4 Others
  6. 5.2 Global Alpha Synuclein Sales by Application
  7. 5.2.1 Global Alpha Synuclein Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Alpha Synuclein Sales by Application (2021-2032)
  9. 5.2.3 Global Alpha Synuclein Sales Market Share by Application (2021-2032)
  10. 5.3 Global Alpha Synuclein Revenue by Application
  11. 5.3.1 Global Alpha Synuclein Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Alpha Synuclein Revenue by Application (2021-2032)
  13. 5.3.3 Global Alpha Synuclein Revenue Market Share by Application (2021-2032)
6 Global Alpha Synuclein Sales by Region
  1. 6.1 Global Alpha Synuclein Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Alpha Synuclein Sales by Region (2021-2032)
  3. 6.2.1 Global Alpha Synuclein Sales by Region (2021-2026)
  4. 6.2.2 Global Alpha Synuclein Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Alpha Synuclein Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Alpha Synuclein Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Alpha Synuclein Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Alpha Synuclein Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Alpha Synuclein Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Alpha Synuclein Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Alpha Synuclein Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Alpha Synuclein Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Alpha Synuclein Revenue by Region
  1. 7.1 Global Alpha Synuclein Revenue by Region
  2. 7.1.1 Global Alpha Synuclein Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Alpha Synuclein Revenue by Region (2021-2026)
  4. 7.1.3 Global Alpha Synuclein Revenue by Region (2027-2032)
  5. 7.1.4 Global Alpha Synuclein Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Alpha Synuclein Revenue (2021-2032)
  8. 7.2.2 North America Alpha Synuclein Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Alpha Synuclein Revenue (2021-2032)
  11. 7.3.2 Europe Alpha Synuclein Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Alpha Synuclein Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Alpha Synuclein Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Alpha Synuclein Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Alpha Synuclein Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Biogen Inc
  2. 8.1.1 Biogen Inc Company Information
  3. 8.1.2 Biogen Inc Business Overview
  4. 8.1.3 Biogen Inc Alpha Synuclein Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Biogen Inc Alpha Synuclein Product Portfolio
  6. 8.1.5 Biogen Inc Recent Developments
  7. 8.2 reMYND NV
  8. 8.2.1 reMYND NV Company Information
  9. 8.2.2 reMYND NV Business Overview
  10. 8.2.3 reMYND NV Alpha Synuclein Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 reMYND NV Alpha Synuclein Product Portfolio
  12. 8.2.5 reMYND NV Recent Developments
  13. 8.3 QR Pharma Inc
  14. 8.3.1 QR Pharma Inc Company Information
  15. 8.3.2 QR Pharma Inc Business Overview
  16. 8.3.3 QR Pharma Inc Alpha Synuclein Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 QR Pharma Inc Alpha Synuclein Product Portfolio
  18. 8.3.5 QR Pharma Inc Recent Developments
  19. 8.4 Prothena Corp Plc
  20. 8.4.1 Prothena Corp Plc Company Information
  21. 8.4.2 Prothena Corp Plc Business Overview
  22. 8.4.3 Prothena Corp Plc Alpha Synuclein Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Prothena Corp Plc Alpha Synuclein Product Portfolio
  24. 8.4.5 Prothena Corp Plc Recent Developments
  25. 8.5 nLife Therapeutics SL
  26. 8.5.1 nLife Therapeutics SL Company Information
  27. 8.5.2 nLife Therapeutics SL Business Overview
  28. 8.5.3 nLife Therapeutics SL Alpha Synuclein Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 nLife Therapeutics SL Alpha Synuclein Product Portfolio
  30. 8.5.5 nLife Therapeutics SL Recent Developments
  31. 8.6 Neuropore Therapies Inc
  32. 8.6.1 Neuropore Therapies Inc Company Information
  33. 8.6.2 Neuropore Therapies Inc Business Overview
  34. 8.6.3 Neuropore Therapies Inc Alpha Synuclein Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Neuropore Therapies Inc Alpha Synuclein Product Portfolio
  36. 8.6.5 Neuropore Therapies Inc Recent Developments
  37. 8.7 MedImmune LLC
  38. 8.7.1 MedImmune LLC Company Information
  39. 8.7.2 MedImmune LLC Business Overview
  40. 8.7.3 MedImmune LLC Alpha Synuclein Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 MedImmune LLC Alpha Synuclein Product Portfolio
  42. 8.7.5 MedImmune LLC Recent Developments
  43. 8.8 ICB International Inc
  44. 8.8.1 ICB International Inc Company Information
  45. 8.8.2 ICB International Inc Business Overview
  46. 8.8.3 ICB International Inc Alpha Synuclein Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 ICB International Inc Alpha Synuclein Product Portfolio
  48. 8.8.5 ICB International Inc Recent Developments
  49. 8.9 H. Lundbeck A/S
  50. 8.9.1 H. Lundbeck A/S Company Information
  51. 8.9.2 H. Lundbeck A/S Business Overview
  52. 8.9.3 H. Lundbeck A/S Alpha Synuclein Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 H. Lundbeck A/S Alpha Synuclein Product Portfolio
  54. 8.9.5 H. Lundbeck A/S Recent Developments
  55. 8.10 Genmab A/S
  56. 8.10.1 Genmab A/S Company Information
  57. 8.10.2 Genmab A/S Business Overview
  58. 8.10.3 Genmab A/S Alpha Synuclein Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Genmab A/S Alpha Synuclein Product Portfolio
  60. 8.10.5 Genmab A/S Recent Developments
  61. 8.11 Evotec AG
  62. 8.11.1 Evotec AG Company Information
  63. 8.11.2 Evotec AG Business Overview
  64. 8.11.3 Evotec AG Alpha Synuclein Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Evotec AG Alpha Synuclein Product Portfolio
  66. 8.11.5 Evotec AG Recent Developments
  67. 8.12 BioArctic AB
  68. 8.12.1 BioArctic AB Company Information
  69. 8.12.2 BioArctic AB Business Overview
  70. 8.12.3 BioArctic AB Alpha Synuclein Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 BioArctic AB Alpha Synuclein Product Portfolio
  72. 8.12.5 BioArctic AB Recent Developments
  73. 8.13 AFFiRiS AG
  74. 8.13.1 AFFiRiS AG Company Information
  75. 8.13.2 AFFiRiS AG Business Overview
  76. 8.13.3 AFFiRiS AG Alpha Synuclein Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 AFFiRiS AG Alpha Synuclein Product Portfolio
  78. 8.13.5 AFFiRiS AG Recent Developments
  79. 8.14 AC Immune SA
  80. 8.14.1 AC Immune SA Company Information
  81. 8.14.2 AC Immune SA Business Overview
  82. 8.14.3 AC Immune SA Alpha Synuclein Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 AC Immune SA Alpha Synuclein Product Portfolio
  84. 8.14.5 AC Immune SA Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Alpha Synuclein Value Chain Analysis
  2. 9.1.1 Alpha Synuclein Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Alpha Synuclein Production Mode & Process
  6. 9.2 Alpha Synuclein Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Alpha Synuclein Distributors
  9. 9.2.3 Alpha Synuclein Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst